BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20729158)

  • 21. Effectiveness of organised versus opportunistic mammography screening.
    Bulliard JL; Ducros C; Jemelin C; Arzel B; Fioretta G; Levi F
    Ann Oncol; 2009 Jul; 20(7):1199-202. PubMed ID: 19282467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Maehlen J
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological changes in breast tumours in Italy: the IMPACT study on mammographic screening programmes.
    IMPACT WORKING Group
    Pathologica; 2011 Oct; 103(5):290-3. PubMed ID: 22393684
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quality assurance in organized screening of breast cancer].
    De Landtsheer JP; Delaloye JF; Lepori D; De Grandi P; Levi F
    Rev Med Suisse Romande; 2003 May; 123(5):283-9. PubMed ID: 15095710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results from the Swiss mammography screening pilot programme.
    Bulliard JL; De Landtsheer JP; Levi F
    Eur J Cancer; 2003 Aug; 39(12):1761-9. PubMed ID: 12888372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The professional quality criteria of Italian breast screening radiologists: results from a national survey comparing the programmes started in 2000-2012 versus the ones started in 1990-1999.
    Morrone D; Giordano L; Artuso F; Bernardi D; Fedato C; Frigerio A; Giorgi D; Naldoni C; Saguatti G; Severi D; Taffurelli M; Terribile D; Ventura L; Bucchi L
    Ann Ist Super Sanita; 2017; 53(2):163-166. PubMed ID: 28617264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 2001; 8(1):24-8. PubMed ID: 11373846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lost opportunity to usefully examine French breast cancer screening mortality.
    Braillon A; Bewley S
    Cancer Epidemiol; 2011 Jun; 35(3):306; author reply 307-8. PubMed ID: 21466985
    [No Abstract]   [Full Text] [Related]  

  • 29. Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.
    Cullati S; von Arx M; Courvoisier DS; Sandoval JL; Manor O; Burton-Jeangros C; Bouchardy C; Guessous I
    Prev Med; 2018 Nov; 116():19-26. PubMed ID: 30145347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summaries for patients: Overdiagnosis of invasive breast cancer with mammography screening.
    Ann Intern Med; 2012 Apr; 156(7):I58. PubMed ID: 22473444
    [No Abstract]   [Full Text] [Related]  

  • 31. Audit feedback on reading performance of screening mammograms: An international comparison.
    Hofvind S; Bennett RL; Brisson J; Lee W; Pelletier E; Flugelman A; Geller B
    J Med Screen; 2016 Sep; 23(3):150-9. PubMed ID: 26892191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of mammography on breast cancer incidence in Vaud, Switzerland.
    Levi F; Te VC; la Vecchia C
    J Natl Cancer Inst; 1991 Aug; 83(16):1181-2. PubMed ID: 1886150
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase.
    Oberaigner W; Buchberger W; Frede T; Daniaux M; Knapp R; Marth C; Siebert U
    BMC Public Health; 2011 Feb; 11():91. PubMed ID: 21306614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
    Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
    BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is variation in quality of mammographic services race linked?
    Jones BA; Culler CS; Kasl SV; Calvocoressi L
    J Health Care Poor Underserved; 2001 Feb; 12(1):113-26. PubMed ID: 11217224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK breast screening programme: how does it reflect the Forrest recommendations?
    Gerard K; Brown J; Johnston K
    J Med Screen; 1997; 4(1):10-5. PubMed ID: 9200055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implementation of performance indicators in the Czech Breast Cancer Screening Programme -  results of the regular monitoring].
    Májek O; Bartoňková H; Daneš J; Skovajsová M; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():113-23. PubMed ID: 25494896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography screening in Switzerland: limited evidence from limited data.
    Zwahlen M; Bopp M; Probst-Hensch NM
    Swiss Med Wkly; 2004 May; 134(21-22):295-306. PubMed ID: 15243841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Process indicators and standards for the evaluation of breast cancer screening programmes].
    Giordano L; Giorgi D; Frigerio A; Bravetti P; Paci E; Petrella M; Ponti A; de' Bianchi PS;
    Epidemiol Prev; 2006; 30(2 Suppl 1):5-9, 11-47. PubMed ID: 16916012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of mammography screening in elderly women.
    Sandstrom-Wakeling SK; Nied L; Gambino K; Zak M; Duffy E
    Nurse Pract; 2003 May; 28(5):50-3. PubMed ID: 12792269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.